Drug intelligence / Profile preview

kaempferia galanga extract

Development stage
Preclinical
Lead developer
Thammasat University
Modality
Small Molecules
Administration
Oral
01

Overview

Kaempferia galanga extract is a natural product derived from the rhizome of the *Kaempferia galanga L.* plant, a member of the Zingiberaceae family commonly known as aromatic ginger or kencur. The extract's primary bioactive constituent is ethyl-p-methoxycinnamate (EPMC). It is characterized by its anti-inflammatory, antioxidant, and cytotoxic properties. Mechanistically, the extract works by inhibiting neutrophil infiltration and modulating the production of pro-inflammatory cytokines, specifically tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). Research, particularly at institutions like Thammasat University, has explored its potential therapeutic applications in inflammatory conditions such as osteoarthritis and various malignancies, including cholangiocarcinoma (bile duct cancer) and hepatocellular carcinoma. While not currently an approved pharmaceutical drug, it is utilized in over-the-counter products and is being investigated in advanced delivery systems like solid self-nanoemulsifying drug delivery systems (S-SNEDDS) and fast disintegrating tablets.

Other names
Kaempferia galanga L. extractkencur extractaromatic ginger extractresurrection lily extract
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)

Beyond the preview

Go deeper on kaempferia galanga extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on kaempferia galanga extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call